Good Startup

Type

Venture Capital

Status

Active

Location

Singapore, Singapore

Total investments

13

Average round size

5M

Portfolio companies

10

Follow on index

0.15

Areas of investment
BiotechnologyRetailArtificial IntelligenceFood and BeverageFood ProcessingMachine LearningManufacturing

Investor highlights

Industry focus
Biotech/Life Sciences
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 34000000
Fund raised date
2022-05-12

Analytics

Total investments
13
Lead investments
0
Follow on index
0.15
Investments by industry
  • Food and Beverage (6)
  • Biotechnology (6)
  • Manufacturing (2)
  • Retail (2)
  • Food Processing (2)
  • Show 2 more
Investments by region
  • China (2)
  • France (1)
  • United States (4)
  • Canada (1)
  • Israel (2)
  • Show 2 more
Peak activity year
2022

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
3
Group Appearance index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
BioRaptor 24 Apr 2024 Artificial Intelligence, Machine Learning Seed Hefa, Hefa, Israel
Novel Farms, Inc. 31 Aug 2021 Biotechnology, Retail, Food and Beverage, Manufacturing Seed 1M United States, California, Berkeley
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.